CannPal Animal Therapeutics Limited


CannPal Animal Therapeutics Ltd (ASX:CP1)CannPal Animal Therapeutics Limited (ASX:CP1) is a listed animal health company developing innovative and naturally derived plant-based therapeutic products for pets targeting the endocannabinoid system that owners can trust are both safe and scientifically validated.

The company has a research focus on cannabinoids, the active pharmaceutical ingredients extracted from the cannabis plant, to provide veterinarians and pet owners with clinically validated and standardised therapeutics to treat animals in a safe and ethical way.

CannPal has identified a significant opportunity to benefit from the rapidly growing medical cannabis and animal health markets by developing innovative therapeutics that can influence the endocannabinoid system with full regulatory approval for veterinary distribution.



AusCann Group Holdings Ltd (ASX:AC8) and CannPal Enter Into Scheme of Arrangement

🕔11/16/2020 12:10:39 PM 3039

AusCann Group Holdings Ltd (ASX:AC8), an Australian based pharmaceutical company focused on the development, production and distribution of cannabinoid-based medicines within Australia and internationally, is pleased to announce that it has entered into a scheme implementation deed (SID) with CannPal Animal Therapeutics Limited.

Read Full Article


  • This Page Viewed: (Last 30 Days: 20) (Since Published: 2150) 

Company Data

  • Level 3, 45a Bay Street
    Double Bay 2028 NSW
  • Telephone
  • +61-2-6108-3622 
  • Principal Sector
  • Cannabis and Hemp 
  • Principal Industry
  • Healthcare 
  • Homepage

Social Media